Dr. Reddy's Laboratories Ltd.
Snapshot View

View in App

Prices View details >>

4564.50 +36.20 ▲0.8%

29 March 2023, 04:01:00 PM
Volume: 8,544

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.drreddys.com
Market Cap 76,011.65 Cr.
Enterprise Value(EV) 76,090.75 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 218.83 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 20.86 Trailing Twelve Months Ending 2022-12
Industry PE 32.17 Trailing Twelve Months Ending 2022-12
Book Value / Share 1,356.34 Trailing Twelve Months Ending 2022-12
Price to Book Value 3.37 Calculated using Price: 4,564.50
Dividend Yield 0.66 Period Ending 2022-03
No. of Shares Subscribed 16.65 Cr. 166,527,876 Shares
FaceValue 5
Company Profile
The company is a leading India-based pharmaceutical company headquartered and having its registered office in Hyderabad, Telangana, India. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the Company offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars and differentiated formulations.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.80%
1 Week
+1.98%
1 Month
+5.87%
3 Month
+7.17%
6 Month
+4.71%
1 Year
+5.62%
2 Year
+3.61%
5 Year
+119.19%
10 Year
+158.42%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 27.88 26.63 18.95 10.20 7.40 14.75 13.76 11.82 11.93
Return on Capital Employed (%) 25.00 22.70 19.55 9.77 8.21 13.66 11.12 15.49 14.59
Return on Assets (%) 13.47 13.67 11.05 6.14 4.23 8.86 9.20 8.21 8.08

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 7,865 9,853 12,570 12,262 12,572 14,024 15,599 17,642 19,212 20,775
Non Curr. Liab. 2,182 1,678 877 456 2,538 2,113 -808 -197 -508 -345
Curr. Liab. 5,790 6,821 6,347 8,420 6,894 5,897 7,214 8,104 9,766 7,987
Minority Int.
Equity & Liab. 15,838 18,353 19,794 21,138 22,004 22,034 22,005 25,548 28,470 28,417
Non Curr. Assets 5,512 6,476 8,000 11,454 11,505 10,924 9,406 10,998 10,682 11,163
Curr. Assets 10,326 11,877 11,794 9,684 10,498 11,110 12,599 14,535 17,788 17,254
Misc. Exp. not W/O
Total Assets 15,838 18,353 19,794 21,138 22,004 22,034 22,005 25,548 28,470 28,417

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 13,415 15,023 15,568 14,196 14,281 15,448 17,517 19,048 21,545 23,829
Other Income 196 275 295 172 155 338 621 291 485 1,075
Total Income 13,611 15,298 15,863 14,368 14,436 15,786 18,138 19,339 22,030 24,905
Total Expenditure -10,165 -11,530 -11,983 -11,724 -11,930 -12,270 -15,047 -15,178 -17,778 -18,600
PBIDT 3,446 3,769 3,880 2,644 2,506 3,516 3,091 4,161 4,252 6,305
Interest -153 -109 -83 -63 -79 -89 -98 -97 -96 -139
Depreciation -648 -760 -939 -1,027 -1,077 -1,135 -1,163 -1,229 -1,165 -1,228
Taxation -683 -563 -751 -297 -438 -386 140 -932 -879 -1,334
Exceptional Items
PAT 1,963 2,336 2,108 1,257 912 1,950 2,026 1,952 2,183 3,604
Minority Interest
Share Associate 23 35 34 40
Other Related Items
Consolidated Net Profit 1,963 2,336 2,131 1,292 947 1,950 2,026 1,952 2,183 3,644
Adjusted EPS 115 137 125 78 57 117 122 117 131 219

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 1,378 1,970 2,524 3,263 2,144 1,803 2,870 2,984 3,570 2,811
Cash Fr. Inv. -1,446 -1,694 -2,265 -2,039 -1,840 -1,488 -773 -492 -2,266 -2,639
Cash Fr. Finan. -157 -24 -433 -1,700 -369 -444 -2,133 -2,516 -30 -242
Net Change -225 251 -174 -477 -65 -129 -35 -24 1,275 -70
Cash & Cash Eqvt 520 862 583 492 378 254 223 196 1,482 1,485

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 26.73 26.74 26.73 26.72 26.72 26.72 26.71 26.71 26.70
Public 60.15 61.06 61.18 61.24 61.75 62.05 62.92 63.21 62.77
Depository Receipts 13.12 12.21 12.09 12.05 11.53 11.23 10.37 10.08 10.53
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 23 Mar 2023
Disclosure Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Thu, 23 Mar 2023
Board Meeting Intimation for Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Financial Year Ending On March 31 2023 And To Recommend Dividend If Any For The Financial Year 2022-23.
DR.REDDYs LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2023 inter alia to consider and approve Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ending on March 31 2023 and to recommend dividend if any for the financial year 2022-23.
Thu, 23 Mar 2023
Closure of Trading Window
The trading window for dealing in securities of the Company will be closed from March 25 2023 to May 12 2023 (both days inclusive).

Technical Scans View Details >>

Wed, 29 Mar 2023
Higher Delivery Quantity Higher Delivery Quantity
Close Crossing Last Month High Close Crossing Last Month High
Closing Above Previous High Closing Above Previous High
Making Higher Highs for 3 days Making Higher Highs for 3 days
Close Within 52 Week High Zone Close Within 52 Week High Zone

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 237,702.12 990.70 +0.7%
Divi's Laboratories Ltd. 74,827.63 2,818.70 +0.5%
Cipla Ltd. 71,662.87 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. 62,756.97 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. 52,113.83 1,554.65 +0.7%
Zydus Lifesciences Ltd. 49,628.37 490.30 +1.2%
Abbott India Ltd. 46,194.07 21,680.65 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 56.44 990.70 +0.7%
Divi's Laboratories Ltd. Consolidated 2022-12 31.22 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 27.16 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 82.20 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 63.32 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 24.08 490.30 +1.2%
Abbott India Ltd. Standalone 2022-12 49.70 21,680.65 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.30 990.70 +0.7%
Divi's Laboratories Ltd. Consolidated 2022-12 6.01 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 3.16 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.19 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.25 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.88 490.30 +1.2%
Abbott India Ltd. Standalone 2022-12 15.60 21,680.65 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 990.70 +0.7%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 0.04 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 490.30 +1.2%
Abbott India Ltd. Standalone 2022-03 0.00 21,680.65 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Abbott India Ltd. Standalone 2022-03 29.95 21,680.65 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Abbott India Ltd. Standalone 2022-03 29.95 21,680.65 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 990.70 +0.7%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 490.30 +1.2%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,680.65 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 990.70 +0.7%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 490.30 +1.2%
Abbott India Ltd. Standalone 2022-03 798.70 21,680.65 +0.4%

FAQ's On Dr. Reddy's Laboratories Ltd.

What is Dr. Reddy's Lab share price?
Can I buy Dr. Reddy's Lab shares now?
What is the Dividend Yield of Dr. Reddy's Lab?
What is the Market Cap of Dr. Reddy's Lab?
What are the key metrics to analyse Dr. Reddy's Lab?
What is the 52 Week High and Low of Dr. Reddy's Lab?
What is the trend of Dr. Reddy's Lab share price?